超重和肥胖成年人的时间限制饮食:证据摘要和临床建议
Hui Liu1, Zhuolian Zheng1, Fuliang Shangguan1
1School of Nursing, University of South China, No. 28, Changsheng West Road, Hengyang, 421001, Hunan, China.
Journal of health, population, and nutrition
|January 12, 2026
概括
时间限制饮食 (TRE) 在超重和肥胖的成年人中显示出对体重管理的前景. 本综述综合了证据,并为临床使用提供了建议.
科学领域:
- 营养科学 营养科学
- 代谢健康 代谢健康
- 基于证据的医学基于证据的医学.
背景情况:
- 超重和肥胖是全球重要的健康问题.
- 缺乏对饮食干预措施的临床指导方针,例如时间限制饮食 (TRE).
- TRE涉及在特定的每日时间窗口内消费食物.
研究的目的:
- 系统地审查TRE对超重/肥胖成年人体重管理的证据.
- 为TRE的临床应用制定基于证据的建议.
- 为弥补TRE特定临床指南的缺口.
主要方法:
- 在9个数据库和6个网站进行系统的文献搜索,直至2024年9月.
- 包括随机对照试验 (RCT),指导方针,共识陈述和系统审查.
- 用JBI框架对39个关键证据进行了主题综合,并对建议进行了分级.
主要成果:
- 从5535个记录中,包括了25篇文章 (5条指导方针,3个共识,8个评论,9个RCT).
- 在TRE中,短期到中期显著减肥,心脏代谢参数有所改善.
- 影响结果的关键因素包括饮食窗口协议和遵守.
结论:
- 时间限制饮食 (TRE) 是对超重和肥胖的成年人有前途的饮食干预措施.
- 本综述提供了一个结构化的证据摘要和TRE的实际建议.
- 未来的研究应该调查长期疗效和对临床终点的影响.
相关概念视频
Binge Eating Disorders
410
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
410
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
217
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
217
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
Regulation of Food Intake
2.3K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.3K


